Definium Accounts Payable from 2010 to 2026

DFTX Stock   16.25  0.78  4.58%   
Definium Therapeutics Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2026. Accounts Payable is the amount Definium Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents Definium Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
1.8 M
Current Value
2.5 M
Quarterly Volatility
913.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Definium Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definium Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 11.2 M or Depreciation And Amortization of 450.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.79. Definium financial statements analysis is a perfect complement when working with Definium Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Definium Stock
Check out the analysis of Definium Therapeutics Correlation against competitors.
For more information on how to buy Definium Stock please use our How to Invest in Definium Therapeutics guide.
The evolution of Accounts Payable for Definium Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Definium Therapeutics compares to historical norms and industry peers.

Latest Definium Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Definium Therapeutics over the last few years. An accounting item on the balance sheet that represents Definium Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Definium Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Definium Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definium Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Definium Accounts Payable Regression Statistics

Arithmetic Mean3,687,588
Geometric Mean3,547,654
Coefficient Of Variation24.78
Mean Deviation745,100
Median4,178,000
Standard Deviation913,700
Sample Variance834.8B
Range2.4M
R-Value(0.70)
Mean Square Error455.5B
R-Squared0.49
Significance0
Slope(126,463)
Total Sum of Squares13.4T

Definium Accounts Payable History

20262.5 M
20251.8 M
2024M
20234.1 M
20222.1 M

About Definium Therapeutics Financial Statements

Definium Therapeutics investors use historical fundamental indicators, such as Definium Therapeutics' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Definium Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable1.8 M2.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Definium Stock Analysis

When running Definium Therapeutics' price analysis, check to measure Definium Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definium Therapeutics is operating at the current time. Most of Definium Therapeutics' value examination focuses on studying past and present price action to predict the probability of Definium Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definium Therapeutics' price. Additionally, you may evaluate how the addition of Definium Therapeutics to your portfolios can decrease your overall portfolio volatility.